Long-term outcome of transverse myelitis (TM) in systemic lupus erythematosus (SLE) and primary antiphospholipid syndrome (PAPS).

被引：0

作者：

Barile, L ^{[1
]}

Juarez, H ^{[1
]}

Ariza, R ^{[1
]}

Fuentes, M ^{[1
]}

Jara, LJ ^{[1
]}

机构：

[1] IMSS,CTR MED LA RAZA,HOSP ESPECIALIDADES,RHEUMAT DIS UNIT,MEXICO CITY 02990,DF,MEXICO

来源：

ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：159 / 159

页数：1

共 50 条

[31] Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: Good functional outcome and relevance of antiphospholipid antibodies [J].

D'Cruz, DP ;

Mellor-Pita, S ;

Joven, B ;

Sanna, G ;

Allanson, J ;

Taylor, J ;

Khamashta, MA ;

Hughes, GRV .

JOURNAL OF RHEUMATOLOGY, 2004, 31 (02) :280-285

[32] Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis [J].

Sloan, RP ;

Schwartz, MM ;

Korbet, SM ;

Borok, RZ .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (02) :299-305

[33] MATERNAL AND FETAL OUTCOME IN MEXICAN WOMEN WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME, SECONDARY ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS WITH ANTIPHOSPHOLIPID ANTIBODIES [J].

Sanchez, A. A. ;

Miranda, D. ;

Saavedra, M. A. ;

Sanchez Gonzalez, A. ;

Castro, Z. .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 :1200-1200

[34] Long-term thalidomide therapy for cutaneous lesions of systemic lupus erythematosus (SLE) [J].

Sato, EI ;

Assis, LSS ;

Furtado, R .

ARTHRITIS AND RHEUMATISM, 1996, 39 (09) :1353-1353

[35] Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in PAPS and APS related to SLE [J].

Andrade, Danieli ;

Ugolini-Lopes, Michelle Remiao ;

Bonfa, Eloisa ;

Torricelli, Aline Kuhl .

LUPUS, 2019, 28 :55-55

[36] Hyperhomocysteinemia in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and antiphospholipid syndrome associated with lupus. [J].

Prieto, MP ;

Muñoz, G ;

Hernández, B ;

López, LA ;

Vargas, A ;

González, EH ;

Valdéz, MR ;

Amigo, MC .

JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) :422-422

[37] Ovulation induction therapy in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). [J].

Du, LTH ;

Wechsler, D ;

Chalumeau-Costedoat, N ;

Vauthier-Brouzes, D ;

de Gennes, C ;

Lefebvre, G ;

Frances, C ;

Piette, JC .

ARTHRITIS AND RHEUMATISM, 2000, 43 (09) :S309-S309

[38] PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

MUJIC, F ;

CUADRADO, MJ ;

LLOYD, M ;

KHAMASHTA, MA ;

PAGE, G ;

HUGHES, GRV .

JOURNAL OF RHEUMATOLOGY, 1995, 22 (08) :1589-1592

[39] Comparison of lung perfusion scintigraphic findings in pulmonary thromboembolism in systemic lupus erythematosus, SLE plus antiphospholipid syndrome, and primary antiphospholipid syndrome [J].

Aung, W ;

Murata, Y ;

Ishida, R ;

Shibuya, H .

NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (03) :299-304

[40] Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome [J].

Guraieb-Chahin, P. ;

Cantu-Brito, C. ;

Soto-Mota, A. ;

Guerrero-Torres, L. ;

Flores-Silva, F. ;

Chiquete, E. ;

Fragoso-Loyo, H. ;

Gonzalez-Duarte, A. ;

Valdes-Ferrer, S., I .

LUPUS, 2020, 29 (05) :437-445

← 1 2 3 4 5 →